Schedule 13G ownership disclosure

Atea Pharmaceuticals Inc

Security class unavailable · CUSIP: 04683R106

Event date: 2021-12-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,376,134
Percent of class
6.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000685
Form type
SC 13G
Filer
Atea Pharmaceuticals, Inc.
CIK
CIK 1593899
Filed
Dec 10, 2021
Reporting period
Dec 01, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub